Analyst Activity – Kepler Capital Markets Reiterates Reduce on GlaxoSmithKline plc (LON:GSK)

ME Staff
-
0

Analyst Ratings For GlaxoSmithKline plc (LON:GSK)

Today, Kepler Capital Markets reiterated its Reduce rating on GlaxoSmithKline plc (LON:GSK) with a price target of GBX 1,520.

There are 4 sell ratings, 11 hold ratings, 8 buy ratings on the stock.

The current consensus rating on GlaxoSmithKline plc (LON:GSK) is Hold (Score: 2.17) with a consensus target price of GBX 1,735.86 per share, a potential .

Some recent analyst ratings include

  • 7/27/2017-Kepler Capital Markets Reiterated Rating of Reduce.
  • 7/27/2017-Barclays PLC Reiterated Rating of Equal weight.
  • 7/27/2017-Liberum Capital Reiterated Rating of Buy.
  • 7/26/2017-Investec Reiterated Rating of Buy.
  • 7/26/2017-Berenberg Bank Reiterated Rating of Buy.


    Recent Trading Activity for GlaxoSmithKline plc (LON:GSK)
    Shares of GlaxoSmithKline plc closed the previous trading session at 1,518.00 down -27.36 -1.77% with 10,819,078 shares trading hands.